Overview
Demographics
Basic patient information
Self
Name:Jane Marie Doe
Preferred Name:Janie
Birth Date:1956-05-12
Gender:Female
Birth Sex:Female
Gender Identity:Female
Pronouns:she/her
Race:White
Emergency Contact
Emergency contact information
Self
Clinical Summary
AI-generated clinical overview
SystemRead-only
Title:Patient Overview
Content:Jane Marie Doe is a 68-year-old female Medicare beneficiary with a complex medical history including type 2 diabetes, essential hypertension, hyperlipidemia, osteoarthritis, and stage 2 chronic kidney disease. She is currently enrolled in the CMS ACCESS CKM (Cardio-Kidney-Metabolic) track for comprehensive metabolic disease management.
Priority:High
Generated Date:2025-01-15
Generated By:HealthTap Clinical AI
SystemRead-only
Title:Active Conditions Requiring Monitoring
Content:Primary concerns include diabetes control (HbA1c 6.8%, target <7.0%), blood pressure control (currently 132/84, target <130/80), LDL cholesterol management (105 mg/dL, target <100), and kidney function preservation (eGFR 70, stage 2 CKD). All four CKM track conditions require coordinated management.
Priority:High
Generated Date:2025-01-15
Generated By:HealthTap Clinical AI
SystemRead-only
Title:Current Medications
Content:Patient is on a well-optimized medication regimen: Lisinopril 20mg daily for hypertension and renal protection, Atorvastatin 40mg for hyperlipidemia, Metformin 500mg BID for glucose control, and Aspirin 81mg for cardiovascular prophylaxis. No significant drug interactions identified.
Priority:Medium
Generated Date:2025-01-15
Generated By:HealthTap Clinical AI
SystemRead-only
Title:Recent Lab Trends
Content:Labs from January 2025 show stable kidney function, improving lipid profile (LDL down from 110 to 105), and controlled glucose metabolism. CBC unremarkable. Recommend continued monitoring every 3-6 months.
Priority:Medium
Generated Date:2025-01-15
Generated By:HealthTap Clinical AI
SystemRead-only
Title:Preventive Care Status
Content:Up to date on: Annual Wellness Visit (Jan 2025), Influenza vaccine (Oct 2024), COVID-19 booster (Sep 2024), Pneumococcal vaccines (complete). Due: Colonoscopy (overdue by 2 years), Mammogram (due Feb 2025), Shingles vaccine second dose.
Priority:Medium
Generated Date:2025-01-15
Generated By:HealthTap Clinical AI
SystemRead-only
Title:Care Gaps & Recommendations
Content:1) Schedule colonoscopy - last performed 2018. 2) Complete shingles vaccine series. 3) Consider referral to dietitian for prediabetes management. 4) Discuss advance care planning during next AWV.
Priority:High
Generated Date:2025-01-15
Generated By:HealthTap Clinical AI
SystemRead-only
Title:ACCESS Program Progress
Content:Enrolled in CKM track since July 2026 for established cardio-kidney-metabolic disease. HbA1c improved from 7.2% to 6.8% (ACHIEVED target <7.0%). Blood pressure improved from 148/92 to 132/84 (89% to goal). LDL reduced from 110 to 105 (50% to goal). eGFR stable at 70 (75% to maintenance goal). Qualified for initial improvement payment tier. Next quarterly update due October 2026.
Priority:High
Generated Date:2025-01-15
Generated By:HealthTap Clinical AI